Quick Answer
Solid Biosciences Inc. reported Operating Income of -$179.21 million for fiscal year 2025.
Solid Biosciences Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$179.21M | -38.1% |
| 2024 | -$129.73M | -24.4% |
| 2023 | -$104.25M | +2.1% |
| 2022 | -$106.45M | -47.3% |
| 2021 | -$72.25M | +18.3% |
| 2020 | -$88.41M | +25.9% |
| 2019 | -$119.32M | -57.6% |
| 2018 | -$75.69M | -38.0% |
| 2017 | -$54.86M | -114.5% |
| 2016 | -$25.58M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$48.06M | -36.6% | -15.3% |
| June 30, 2025 | -$41.69M | -50.0% | -4.1% |
| March 31, 2025 | -$40.05M | -49.1% | -13.8% |
| September 30, 2024 | -$35.18M | -52.2% | -26.6% |
| June 30, 2024 | -$27.79M | -3.5% | -3.4% |
| March 31, 2024 | -$26.86M | +16.1% | -16.2% |
| September 30, 2023 | -$23.11M | -9.4% | +13.9% |
| June 30, 2023 | -$26.84M | -5.8% | +16.2% |
- Solid Biosciences Inc. showed a decrease of -38.1% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Solid Biosciences Inc.’s operating income has declined by 600.7% (from -$25.58 million to -$179.21 million).
- The most recent figure is from Solid Biosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: